![]() |
|
K. L. Ong (1), A. W. K. Tso (1), S. S. Cherny (2), P. C. Sham (2), K. S. L. Lam (1), C. Q. Jiang (3), G. N. Thomas (4), T. H. Lam (5), B. M. Y. Cheung (1)
(1) Department of Medicine, University of Hong Kong, Hong Kong; (2) Department of Psychiatry and Genome Research Centre, University of Hong Kong, Hong Kong; (3) Guangzhou no. 12 Hospital, Guangzhou, China; (4) Department of Public Health and Epidemiology, University of Birmingham, UK; (5) Department of Community Medicine, University of Hong Kong, Hong Kong
Fibrinogen, a major determinant of blood viscosity, is an acute phase protein associated with cardiovascular disease. We studied the association of hypertension with single nucleotide polymorphisms (SNPs) in the gene encoding the fibrinogen β chain ( FGB ). Three tagging SNPs (rs1025154, rs4220 and rs1044291) were selected from the HapMap database on Han Chinese. Genotypes were determined in 1,294 unrelated subjects from the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort. There were 199 hypertensive subjects at baseline. Among 1,095 subjects normotensive at baseline, 178 developed hypertension during a median follow-up period of 6.4 years. Among the three tagging SNPs, rs4220 showed significant association with hypertension at both baseline (odds ratio [OR]=1.49, p=0.004) and at follow-up (OR=1.32, p=0.013). The minor A allele of this SNP was associated with higher plasma fibrinogen level (β=0.144, p<0.001 at baseline and β=0.130, p<0.001 at follow-up). Among subjects normotensive at baseline, this SNP was also associated with the development of hypertension in men (OR=1.52, p=0.022), but not in women. The SNP rs4220 in FGB , which leads to the substitution of arginine by lysine at position 448, is independently associated with plasma fibrinogen level and hypertension in Hong Kong Chinese. This suggests a possible causal role of fibrinogen in hypertension development, especially in men.
hypertension, fibrinogen, single nucleotide polymorphisms
| 1. | ||
Cara L. Carty1, Mary Cushman2, Daniel Jones2, Leslie A. Lange3, Lucia A. Hindorff1, Kenneth Rice4, Nancy S. Jenny2, J. Peter Durda2, Jeremy Walston5, Christopher S. Carlson6, Debbie Nickerson7, Russell P. Tracy2, Alex P. Reiner1 Thrombosis and Haemostasis 2008 99 2: 388-395 http://dx.doi.org/10.1160/TH07-08-0523 | ||
| 2. | ||
Melanie Kolz1; Jens Baumert1; Henning Gohlke1; Harald Grallert1; Angela Döring1; Annette Peters1; H.-Erich Wichmann1,2; Wolfgang Koenig3; Thomas Illig1 Thrombosis and Haemostasis 2009 101 2: 317-324 http://dx.doi.org/10.1160/TH08-06-0411 | ||
| 3. | ||
Arindam Maitra1, Jayashree Shanker1, Debabrata Dash1, Shibu John2, Prathima R. Sannappa1, Veena S. Rao3, Jayakumar K. Ramanna4, Vijay V. Kakkar5–7 Thrombosis and Haemostasis 2008 99 5: 944-950 http://dx.doi.org/10.1160/TH07-11-0686 | ||